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Extracellular ATP elicits biological responses ranging 
from cell death to synaptic transmission. Recent gene- 
cloning efforts have uncovered a family of cell-surface 
ATP receptors, which are potential targets for the 
development of novel drugs to treat airway and 
cardiovascular diseases, inflammation and pain. 
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Adenosine triphosphate (ATP) is best known as the 
molecular currency of intracellular energy stores. Less 
well appreciated is its multifaceted role as an extracellular 
signaling molecule acting through cell-surface receptors. 
Within the cardiovascular, immune, and nervous systems, 
ATP modulates a plethora of physiological states and cel- 
lular responses, including vascular tone, electrolyte trans- 
port, mast cell degranulation, and synaptic transmission in 
the central nervous system and periphery. Physiological 
and pharmacological studies have convincingly shown that 
ATP exerts its actions by binding to a family of function- 
ally distinct cell-surface receptors, known as purinergic 
type 2, or P,, receptors [l]. This is a notable achievement 
given that there are almost no receptor-subtype-selective 
antagonists or radioligands available to aid in the charac- 
terization of ATP-mediated responses or ATP-binding 
sites. Despite the limitations imposed by this lack of 
pharmacological tools, it was proposed several years ago 
[2,3] that ATP resembles certain other neurotransmitters 
in its ability to activate both G-protein-coupled receptors 
(the I’,,, P,,, and P,, subtypes) and ligand-gated ion 
channels (P,, and P,, subtypes), and that these receptor 
types could be distinguished by their agonist sensitivities 
and signal-transduction mechanisms. These predictions 
have been borne out by the recent characterization of 
functional cDNA clones encoding numerous members of 
the ATP-receptor family. 
Molecular characterization of ATP receptors 
The first members of the P2-receptor family to be cloned 
corresponded to the P,, and P,, subtypes, as evidenced by 
their pharmacological properties when expressed in 
Xenopus oocytes [4,5]. Examination of their deduced 
protein sequences showed them to be members of the 
superfamily of G-protein-coupled receptors, forming a dis- 
tinct branch of the family that is more closely related to 
receptors for platelet-activating factor, angiotensin II, inter- 
leukin-8A and thrombin than to receptors for adenosine 
and CAMP. Other members of this gene family have now 
been cloned from a variety of tissues and organisms. 
Functional analysis of these cloned receptors reveals a 
diversity of subtypes beyond that previously detected 
using available pharmacological tools. Although these 
cloned receptor subtypes all share the ability to transduce 
signals via the activation of phospholipase C and the 
mobilization of intracellular calcium, they are differen- 
tially sensitive to a variety of nucleotide agonists. To 
accommodate this new molecular information, a revised 
nomenclature has been proposed [6] for purinergic recep- 
tors, in which G-protein-coupled purinergic receptors are 
designated P,,,, P,,,, etc., as a function of their sequence 
similarity (an updated compendium of purinergic recep- 
tors is currently maintained at a site on the World Wide 
Web (http://mgddkl.niddk.nih.gov:BOOO/)). 
Perhaps the most surprising outcome to arise from the mol- 
ecular cloning of ATP receptors has been the recent dis- 
covery of a family of P,, receptors that defines a novel 
structural motif for ligand-gated ion channels. Many excita- 
tory and inhibitory ligand-gated ion channels share a 
common subunit structure in which a large amino-terminal, 
extracellular, ligand-binding domain is followed by four 
transmembrane segments. For the best characterized 
member of this channel superfamily, the nicotinic acetyl- 
choline receptor (nAChR), five subunits assemble to delin- 
eate a central water-filled ion pore. Because the biophysical 
properties of native P,, receptors resemble those of 
nAChRs, it was expected that these proteins would have a 
common structural design. But the deduced protein 
sequences of the first two ATP-gated channel subtypes to 
be cloned (P,,, from rat vas deferens smooth muscle and 
PZx2 from the PC-12 rat pheochromocytoma cell line) 
suggest a subunit and receptor structure that is quite differ- 
ent from that of the nAChR [7,8] (Fig. 1). Each of these 
P zx subunits is predicted to have a topology in which two 
transmembrane segments are separated by a large extracel- 
lular ligand-binding loop, with amino and carboxyl termini 
residing within the cytoplasm. 
Although the P,, receptors bear no sequence similarity to 
other signal transduction proteins, their predicted topolog- 
ical organization is reminiscent of that proposed for the 
family of voltage-insensitive ion channels [9], which 
include inwardly-rectifying and pH-sensitive potassium 
channels, amiloride-sensitive sodium channels and pre- 
sumptive mechanosensory ion channels from worms. 
Recent studies suggest that these channel complexes may 
be composed of four subunits, but the stoichiometry of 
functional ATP-gated channels has yet to be determined. 
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Figure 1 
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Predicted structures of (a) a nAChR and (b) 
an ionotropic ATP receptor. In both cases the 
M2 transmembrane segment is predicted to 
form the ion-conducting pore. The subunit 
stoichiometry of the nAChR is well 
established, while that of the ionotropic ATP 
receptor remains speculative. Arrows 
represent glycosylation sites. 
When the first two P,, receptors were cloned, the only 
entry in the sequence databases showing any sequence 
similarity was a partial cDNA clone called RP-2; this clone 
was isolated in a screen designed to identify genes whose 
expression is induced during programmed cell death in rat 
thymocytes [lo]. As it turns out, RP-2 encodes a protein 
corresponding to PZxl. In the light of previous observa- 
tions that extracellular ATP can elicit programmed cell 
death in thymocytes and other cell types (e.g., see [l l]), 
this cloning convergence provides additional evidence to 
support the intriguing notion that ATP might act as a 
paracrine or autocrine signaling molecule during apoptotic 
death in some physiological systems. 
Cloned cDNAs representing at least six different P,, sub- 
types have now been reported (see [12] and references 
therein) and all are capable of forming functional homo- 
merit channel complexes when expressed in Xenopzls 
oocytes or transfected mammalian cells. In general, these 
channels resemble native P,, receptors in showing a lack 
of selectivity among small monovalent cations, a reversal 
potential near zero millivolts, and an inward rectification 
of their current-voltage relationships. Some channels also 
exhibit a relatively high permeability to calcium ions and a 
marked potentiation of ATP-elicited current responses in 
the presence of extracellular zinc. These properties may 
be important for the function of P,, receptors in the long- 
term modulation of cellular processes such as cell death 
(apoptosis) or synaptic plasticity. 
Properties of these heterologously expressed cDNAs 
appear to account for many, but by no means all, of the 
diversity of ATP-gated channels studied in various tissue 
preparations. This suggests that there are still more sub- 
types to be cloned and/or that some of the native receptors 
are heteromeric complexes formed by association of differ- 
ent subunits. The formation of heteromers between P,,, 
and pm receptors has been observed; co-expression of 
these two subunits results in the formation of ATP-gated 
channels with properties different from those of either of 
the homomeric channels [13,14]. The properties of these 
heteromeric channels resemble those reported for chan- 
nels found in sensory neurons of the nodose ganglion and 
dorsal root ganglion (namely a slowly desensitizing 
response to a$-methylene ATP) [15]. As discussed below, 
the sensory nervous system represents a particularly inter- 
esting opportunity for molecular biology to clarify the 
subunit composition of native ATP-gated channel com- 
plexes within the pain signaling pathway. Defining the 
structure and expression of P,, receptors will provide a 
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basis for the rational design of novel therapeutic agents for 
the control of pain. 
ATP and pain 
It has been over forty years since Holton and Holton [16] 
suggested that ATP released from sensory neurons is 
important in synaptic transmission. Building on this early 
observation, other investigators sought to establish that 
ATP acts as a neurotransmitter, directly activating the 
dorsal horn neurons that are responsible for pain transduc- 
tion in the spinal cord. Early stLLdies were limited by the 
fact that ATP is actively metabolized to adenosine in the 
extracellular space. Adenosine is now recognized as an 
inhibitory transmitter in the dorsal horn of the spinal cord, 
acting through its own family of purinergic (P,) receptors 
[17,18]. With the development of neuronal cell culture 
preparations and patch-clamp recording methods, ATP has 
been unambiguously identified as a direct activator of ion 
channels on spinal cord dorsal horn neurons and primary 
afferent neurons from a variety of sources, including both 
somatic and visceral sensory ganglia [ 191. 
What might be the role of these channels in the sensory 
transduction of pain, both at the site of tissue damage 
and at spinal cord synapses that relay sensory information 
to the brain? ATP released from damaged cells into the 
extracellular space could activate primary afferent noci- 
ceptors, specialized sensory neurons that transduce 
intense thermal, mechanical, and noxious chemical 
stimuli into the electrochemical signals of pain. This 
hypothesis is supported by the observation that ATP 
induces pain in a human blister-based model [ZO]. Direct 
evidence for the selective expression of ATP-gated chan- 
nels in sensory neurons has been provided by the cloning 
of several P,, subtypes. As mentioned above, the PZX3 
subtype, whose expression is restricted to sensory 
neurons [14], can assemble with the more widely 
expressed PZXZ subunit. Together, these subtypes form 
ATP-gated channels whose properties resemble native 
receptors found on sensory neurons [ 131. As these cloned 
receptor subunits have just become available for study, 
their role in signal transduction in nociceptors and other 
sensory neurons can now be more fully explored. 
The notion that ATP has a role in the spinal cord pain 
pathway is supported by observations that the P, antago- 
nist suramin can reduce pain transduction in rats when 
placed in the cerebrospinal fluid at the level of the spinal 
cord. Similar administration of the P,, receptor agonists 
a,B-methylene ATP or Z-methylthio ATP reduces the 
latency of a pain response to a heat stimulus applied to the 
tail, which is interpreted as enhancing pain signal trans- 
duction [Zl]. At the molecular level, most PZw receptor 
subtypes cloned to date show significant expression 
within the spinal cord [1’2], including superficial layers of 
the dorsal horn, where primary afferent nociceptors make 
synaptic connections with spinal interneurons. These 
interneurons connect with both local reflex loops and 
ascending pathways that transmit sensory signals to the 
brain, where they are ultimately perceived as pain. Whole- 
cell electrophysiological recordings from a subset of dorsal 
horn neurons suggest that ATP is an enhancer of the exci- 
tatory actions of the neurotransmitter glutamate, but it 
remains possible that ATP is itself a principal excitatory 
agent within the spinal cord [Z?]. 
A new frontier for drug design 
ATP is fast being recognized as an important extracellular 
signaling molecule in a vast array of biological processes. 
Nevertheless, the pharmacopo5a available for the study 
and manipulation of ATP receptors is still rather primi- 
tive. As molecular studies show, the ATP-receptor family 
is more complex than previously appreciated, and the 
need for receptor-subtype-selective drugs has become all 
the more apparent. For example, the PZX4 receptor 
subtype is relatively insensitive to many compounds com- 
monly used to define PZx sites [23]. Thus, identifying 
fast, excitatory responses to ATP in V&J will require the 
development of new compounds that can distinguish 
synaptic events mediated by ATP from those elicited by 
other excitatory transmitters. Further motivation for the 
development of specific and potent ATP-receptor ago- 
nists and antagonists is provided by the possibility that 
these drugs may be useful in the management of common 
physiologic disorder, including pulmonary and cardio- 
vascular disease, urologic dysfunction, inflammation and 
pain syndromes. 
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